News from National ACEP, Oct. 2016

October 01, 2016 11:42 AM | Sally Winkelman (Administrator)

New Epinephrine Labeling:
There has been a change to the labeling of epinephrine. Epi 1:1000 used for anaphylaxis and asthma is now labeled 1.0mg/ml. Epi 1:10,000 used for cardiac arrests is now labeled 0.1 mg/ml. There has been concern that the current labeling caused confusion and inappropriate dosing. 

New Crowding Solutions Resource: 
A new information paper on the causes, impacts and solutions to the crowding and boarding problem has been approved by the Board of Directors.  Members are encouraged to distribute this reader-friendly paper to their hospital administrators or local policymakers who may benefit from a better understanding of why they must, and how they can, address this vexing and dangerous problem. A link to the new paper entitled “Emergency Department Crowding: High Impact Solutions” is available at:

Blood Clot Information for Patients Developed:

ACEP (through an educational grant from Bristol Myers Squibb) is providing UNBRANDED resources to patients with newly diagnosed VTE/PE. The program provides text messages to connect patients to video based education which discusses the importance of taking medication and getting follow up. No product name is mentioned or implied. The program is called Know Blood Clots, and is explained on the website Patients can also text CLOTWEB to 412-652-3744 to sign up for the Know Blood Clots program. If you have questions, feel free to email and I will try to supply further details.

New Sections at ACEP:
A sufficient number of members have come together to officially form three new Sections in the College. The Pain Management Section was formed earlier this year and is now being followed by the creation of the Medical Directors Section and the Event Medicine Section. The new Sections will meet at ACEP16 for the first time. Members interested in any of these topics are invited to attend the Section meetings and/or join the new Sections.